@ARTICLE{
author={Atreya Raja|,Peyrin-Biroulet Laurent|,Klymenko Andrii|,Augustyn Monica|,Bakulin Igor|,Slankamenac Dusan S|,Miheller Pal|,Gasbarrini Antonio|,Hebuterne Xavier|,Arnesson Karin|,Knittel Thomas|,Kowalski Jan|,Neurath Markus F|,Sandborn William J|,Reinisch Walter|},
year={2020},
title={Cobitolimod for moderate-to-severe, left-sided ulcerative colitis (CONDUCT): a phase 2b randomised, double-blind, placebo-controlled, dose-ranging induction trial},
journal={LANCET GASTROENTEROLOGY & HEPATOLOGY},
volume={5},
number={12},
pages={1063-1075},
document_type={Article},
}